UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Editorial Expression of Concern: Herpes simplex virus thymidine kinase/ganciclovir-induced cell death is enhanced by co-expression of caspase-3 in ovarian carcinoma cells

Cancer gene therapy, 2024-06, Vol.31 (6), p.955-955

2024

Volltextzugriff (PDF)

A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer

Annals of oncology, 2014-10, Vol.25 (10), p.1988-1995

2014

Volltextzugriff (PDF)

A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer

British journal of cancer, 2014-04, Vol.110 (8), p.1923-1929

2014

Volltextzugriff (PDF)

Safe administration of chemotherapy in mast cell activation syndrome

Journal of oncology pharmacy practice, 2021-06, Vol.27 (4), p.1005-1010

2021

Volltextzugriff (PDF)

Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer

Oncogene, 2008-05, Vol.27 (22), p.3081-3090

2008

Volltextzugriff (PDF)

Low-Risk Persistent Gestational Trophoblastic Disease: Outcome After Initial Treatment With Low-Dose Methotrexate and Folinic Acid From 1992 to 2000

Journal of clinical oncology, 2002-04, Vol.20 (7), p.1838-1844

2002

Volltextzugriff (PDF)

Routine germline BRCA1 and BRCA2 testing in patients with ovarian carcinoma: analysis of the Scottish real‐life experience

BJOG : an international journal of obstetrics and gynaecology, 2018-10, Vol.125 (11), p.1451-1458

2018

Volltextzugriff (PDF)

Is more of a good thing still a good thing? PARP inhibitor retreatment in high-grade ovarian carcinoma

Annals of oncology, 2023-12, Vol.34 (12), p.1074-1076

2023

Volltextzugriff (PDF)

Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer

Oncogene, 2010-11, Vol.29 (45), p.6051-6063

2010

Volltextzugriff (PDF)

Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium

British journal of cancer, 2017-05, Vol.116 (10), p.1294-1301

2017

Volltextzugriff (PDF)

Gene Therapy Progress and Prospects: cancer gene therapy using tumour suppressor genes

Gene therapy, 2004-03, Vol.11 (6), p.497-503

2004

Volltextzugriff (PDF)

Prognostic pathways in early-stage ovarian cancer: can gene expression transcend histological subtype?

Annals of oncology, 2016-08, Vol.27 (8), p.1366-1368

McNeish, I.A.

2016

Volltextzugriff (PDF)

Are rigid management protocols stifling innovation in cancer treatment?

BJOG : an international journal of obstetrics and gynaecology, 2015-10, Vol.122 (11), p.1432-1434

2015

Volltextzugriff (PDF)

HRD testing for all advanced high-grade ovarian carcinoma in first line?

ESMO open, 2024-07, Vol.9 (7), p.103627, Article 103627

2024

Volltextzugriff (PDF)

A novel cell line panel reveals non-genetic mediators of platinum resistance and phenotypic diversity in high grade serous ovarian cancer

Gynecologic oncology, 2022-10, Vol.167 (1), p.96-106

2022

Volltextzugriff (PDF)

Methanol-based fixation is superior to buffered formalin for next-generation sequencing of DNA from clinical cancer samples

Annals of oncology, 2016-03, Vol.27 (3), p.532-539

2016

Volltextzugriff (PDF)

openFrame: A modular, sustainable, open microscopy platform with single-shot, dual-axis optical autofocus module providing high precision and long range of operation

Journal of microscopy (Oxford), 2023-11, Vol.292 (2), p.64-77

2023

Volltextzugriff (PDF)

Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway

Experimental cell research, 2003-06, Vol.286 (2), p.186-198

2003

Volltextzugriff (PDF)

Virus directed enzyme prodrug therapy for ovarian and pancreatic cancer using retrovirally delivered E. coli nitroreductase and CB1954

Gene therapy, 1998-08, Vol.5 (8), p.1061-1069

1998

Volltextzugriff (PDF)

Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours

British journal of cancer, 2004-03, Vol.90 (6), p.1169-1175

2004

Volltextzugriff (PDF)

Survivin interacts with Smac/DIABLO in ovarian carcinoma cells but is redundant in Smac-mediated apoptosis

Experimental cell research, 2005, Vol.302 (1), p.69-82

2005

Volltextzugriff (PDF)

Response to neoadjuvant chemotherapy in ICON8: A GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/ fallopian tube/ primary peritoneal carcinoma (EOC) treatment

Annals of oncology, 2018-10, Vol.29, p.viii336-viii336

2018

Volltextzugriff (PDF)

Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium

Oncogene, 2012-11, Vol.31 (48), p.4987-4995

2012

Volltextzugriff (PDF)

Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirus vector‐mediated expression of E. coli nitroreductase

International journal of cancer, 2000-06, Vol.86 (6), p.848-854

2000

Volltextzugriff (PDF)

Gene transfer: Bax to the future for cancer therapy

Gut, 2004-04, Vol.53 (4), p.478-479

2004

Volltextzugriff (PDF)

1 – 25 von 1.177

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(893)
Mit Volltextzugriff
(971)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.177)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(471)
Journals@Ovid Complete
(404)
MEDLINE
(397)
Ingenta
(361)
Single Journals
(289)
IngentaConnect Journals
(180)
eBooks on EBSCOhost
(175)
Ebook Central Perpetual and DDA
(174)
Elsevier ScienceDirect Journals Complete
(167)
Wiley-Blackwell Journals
(133)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(126)
BMJ Journals
(91)
Taylor & Francis eBooks A-Z
(90)
Taylor & Francis Current Content Access
(70)
Wiley Online Library Full Collection 2018
(69)
Taylor & Francis Journals
(68)
Taylor & Francis:Master (3349 titles)
(63)
JSTOR
(58)
Nature Journals Online
(57)
Nexis Uni
(52)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(49)
The Lancet
(36)
Cancer Research
(33)
Archives Of Disease In Childhood
(32)
International Journal Of Gynecological Cancer
(32)
Journal Of Clinical Oncology
(29)
Clinical Cancer Research
(28)
Pediatric Research
(18)
Gynecologic Oncology
(17)
European Journal Of Cancer
(15)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Editorial Expression of Concern: Herpes simplex virus thymidine kinase/ganciclovir-induced cell death is enhanced by co-expression of caspase-3 in ovarian carcinoma cells

A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer

A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer

Safe administration of chemotherapy in mast cell activation syndrome

Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer

Low-Risk Persistent Gestational Trophoblastic Disease: Outcome After Initial Treatment With Low-Dose Methotrexate and Folinic Acid From 1992 to 2000

Routine germline BRCA1 and BRCA2 testing in patients with ovarian carcinoma: analysis of the Scottish real‐life experience

Is more of a good thing still a good thing? PARP inhibitor retreatment in high-grade ovarian carcinoma

Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer

Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium

Gene Therapy Progress and Prospects: cancer gene therapy using tumour suppressor genes

Prognostic pathways in early-stage ovarian cancer: can gene expression transcend histological subtype?

Are rigid management protocols stifling innovation in cancer treatment?

HRD testing for all advanced high-grade ovarian carcinoma in first line?

A novel cell line panel reveals non-genetic mediators of platinum resistance and phenotypic diversity in high grade serous ovarian cancer

Methanol-based fixation is superior to buffered formalin for next-generation sequencing of DNA from clinical cancer samples

openFrame: A modular, sustainable, open microscopy platform with single-shot, dual-axis optical autofocus module providing high precision and long range of operation

Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway

Virus directed enzyme prodrug therapy for ovarian and pancreatic cancer using retrovirally delivered E. coli nitroreductase and CB1954

Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours

Survivin interacts with Smac/DIABLO in ovarian carcinoma cells but is redundant in Smac-mediated apoptosis

Response to neoadjuvant chemotherapy in ICON8: A GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/ fallopian tube/ primary peritoneal carcinoma (EOC) treatment

Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium

Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirus vector‐mediated expression of E. coli nitroreductase

Gene transfer: Bax to the future for cancer therapy

Suchergebnisse filtern